We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Orchid Cellmark Awarded Forensic DNA Contracts

By Labmedica staff writers
Posted on 11 Oct 2006
Orchid Cellmark Inc., a provider of identity DNA testing services, has announced that its UK operation, Orchid Cellmark Ltd., (Abingdon, UK), has been awarded new DNA contracts with police forces in Kent, Sussex, and London.

Orchid Cellmark was awarded a three-year exclusive contract to provide DNA testing for PACE (Police and Criminal Evidence Act) and crime scene stain-profiling services for Kent and Sussex police forces. More...
There is an option to extend the contract for an additional two years. The company will also provide DNA testing services for PACE mouth swab samples for police in London. The contract is for five years.

The crime scene stain service provided to Kent and Sussex police forces involves the DNA analysis of items recovered from crimes such as burglary and car theft. There are usually no suspects in these cases and any resulting profiles are submitted to the UK National DNA Database for intelligence purposes. The shorter the time interval between the offense date and provision of intelligence from the UK National DNA Database, the greater the chance of police recovering property belonging to a complainant for offenses such as burglary.

The UK operation of Orchid Cellmark provides British customers with a full range of forensic DNA services. From the routine testing of DNA samples for submission to the National DNA Database to the collection and analysis of evidence for the investigation of the most serious crimes, Orchid Cellmark is capable of attaining results from particularly small and compromised samples. The company currently provides most of its forensic DNA services in the United Kingdom through a subcontract relationship with Forensic Alliance Ltd. This relationship is being terminated and the company is now providing its services directly to UK police forces.

Thomas Bologna, president and CEO of Orchid Cellmark Inc., commented, "We believe our DNA forensic operations in the UK are second to none in providing innovation, quality, and rapid testing turnaround time, and we are very pleased that these three important police forces have awarded contracts to Orchid Cellmark. Equally important, we believe that obtaining this business suggests that our plan to provide forensic services directly to UK police forces is proceeding well.”



Related Links:
Orchid Cellmark

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.